Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ARCT

Arcturus Therapeutics Holdings Inc

May 13 • 04:00PM ET

8.26

+0.01 0.12 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NVAX INO OCGN BEAM PRME

| Held by: ARKG VTI IWM VXF IBB IWN SCHA VTWO PRFZ DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.82	Insider Own	8.43%	Shs Outstand	28.42M	Perf Week	-9.53%
Market Cap	234.77M	Forward P/E	-	EPS next Y	-3.66	Insider Trans	0.00%	Shs Float	26.03M	Perf Month	-4.84%
Enterprise Value	47.38M	PEG	-	EPS next Q	-0.98	Inst Own	80.80%	Short Float	24.75%	Perf Quarter	11.62%
Income	-78.67M	P/S	5.54	EPS this Y	-67.32%	Inst Trans	-8.12%	Short Ratio	13.78	Perf Half Y	-5.92%
Sales	42.35M	P/B	1.23	EPS next Y	8.82%	ROA	-27.26%	Short Interest	6.44M	Perf YTD	34.75%
Book/sh	6.73	P/C	1.11	EPS next 5Y	11.11%	ROE	-37.01%	52W High	24.17 -65.83%	Perf Year	-30.35%
Cash/sh	7.44	P/FCF	-	EPS past 3/5Y	- 7.53%	ROIC	-37.28%	52W Low	5.85 41.20%	Perf 3Y	-72.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-31.15% 47.77%	Gross Margin	93.06%	Volatility	10.52% 6.70%	Perf 5Y	-67.97%
Dividend TTM	-	EV/Sales	1.12	EPS Y/Y TTM	-11.57%	Oper. Margin	-212.05%	ATR (14)	0.60	Perf 10Y	-70.72%
Dividend Ex-Date	-	Quick Ratio	6.31	Sales Y/Y TTM	-67.73%	Profit Margin	-185.75%	RSI (14)	47.10	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	6.31	EPS Q/Q	-82.69%	SMA20	-4.67%	Beta	2.41	Target Price	19.89
Payout	-	Debt/Eq	0.13	Sales Q/Q	-97.61%	SMA50	4.09%	Rel Volume	0.82	Prev Close	8.25
Employees	111	LT Debt/Eq	0.10	Earnings	May 07 AMC	SMA200	-23.38%	Avg Volume	467.35K	Price	8.26
IPO	May 22, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.93% -67.26%	Trades		Volume	384,840	Change	0.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)